Goldman Sachs lowered the firm’s price target on Avantor (AVTR) to $26 from $28 and keeps a Buy rating on the shares after its Q3 results and affirmed guidance. The firm notes that it was “pleased” with the strong free cash flow generation in the quarter and the gradual improvement in bioprocessing and equipment & instrumentation revenue which exceeded its expectations coming into the quarter, and while the management is not providing guidance on 2025, Goldman is assuming a continuation of a slow and steady improvement throughout the FY2, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AVTR:
- Avantor price target lowered to $25 from $28 at Barclays
- Morning Movers: Capri sinks after judge blocks planned takeover by Tapestry
- Avantor reports Q3 adjusted EPS 26c, consensus 25c
- Avantor expands partnership with NIBRT
- AVTR Earnings this Week: How Will it Perform?
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
